Syneos Health Signs Agreement with Singapore General Hospital, Further Expanding Catalyst Site Program
octobre 27, 2023
MORRISVILLE, N.C. – octobre 27, 2023 – Syneos Heath Inc., a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with Singapore General Hospital. This expands the Company’s clinical trial capabilities across a broader range of therapeutic areas in Singapore.
Singapore General Hospital now joins the Syneos Health Catalyst Site Program, which was introduced in 2016 to strengthen collaborations with clinical research sites worldwide. The program harnesses insights from sites across the globe to drive continuous improvement and develop best practices in clinical research delivery.
“Syneos Health is committed to cultivating enduring and productive site relationships. We strive to create a partnership ecosystem that allows us to better navigate the intricacies of highly regulated and complex environments, ensuring the consistent delivery of quality results and streamlined processes in clinical trials,” said Serena Chan, Head of Asia Pacific, Clinical Operations and General Manager Southeast Asia, Clinical Development, Syneos Health. “We look forward to working more closely with Singapore General Hospital to meet the needs of patients in the region.”
Syneos Health has relationships with more than 100 Catalyst sites worldwide and the Company has been acknowledged by the Society for Clinical Research Sites as a recipient of the Eagle Award for demonstrating dedication to establishing strong site partnerships.
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. Nous traduisons des perspectives cliniques, d’affaires médicales et commerciales uniques en résultats qui répondent aux réalités du marché actuel.
Nous réunissons une équipe de professionnels talentueux qui travaillent dans plus de 110 pays et qui ont une connaissance approfondie des comportements des patients et des médecins, ainsi que de la dynamique du marché.
Ensemble, nous partageons des connaissances, utilisons les dernières technologies et appliquons des pratiques commerciales de pointe pour accélérer la livraison d’importants traitements par nos clients aux patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
Media Contact:
Gary Gatyas
Executive Director, External Communications
+1 908 763 3428
